Welcome to our dedicated page for Evercommerce news (Ticker: EVCM), a resource for investors and traders seeking the latest updates and insights on Evercommerce stock.
EverCommerce Inc. reports developments for a service commerce software platform serving small and medium-sized businesses in home services, health services, and wellness services. Its EverPro, EverHealth, and EverWell brands provide vertically tailored SaaS, AI-driven workflows, business management software, embedded payment acceptance, marketing technology, and customer experience applications.
Recurring company news includes quarterly financial results and guidance, subscription and transaction fee trends, Adjusted EBITDA commentary, share repurchase authorization updates, product launches such as EverHealth Scribe within DrChrono, strategic AI partnerships, investor conference appearances, and portfolio changes involving service-industry marketing capabilities.
EverCommerce (NASDAQ: EVCM) reported Q1 2026 results for the quarter ended March 31, 2026: revenue $147.5M (+3.6% YoY), pro forma revenue $147.5M (+3.0% pro forma), net income $7.2M ($0.04/sh), and Adjusted EBITDA $40.7M. The company repurchased 1.3M shares for ~$13.9M and issued Q2 and FY2026 guidance ranges. Conference call scheduled May 7, 2026 at 5:00 p.m. ET.
EverCommerce (NASDAQ: EVCM) will report Q1 2026 financial results after U.S. markets close on Thursday, May 7, 2026. Management will host a conference call the same day at 5:00 p.m. ET / 3:00 p.m. MT to discuss results and provide a business update.
According to the company, investors can access the telephonic webcast and archived replay via the company’s Investor Relations website.
EverCommerce (NASDAQ: EVCM) reported fourth quarter and full year 2025 results on March 12, 2026. Q4 revenue from continuing operations was $151.2 million (+5.2% year-over-year) and Adjusted EBITDA was $44.2 million. Net income from continuing operations was $5.7 million ($0.03 per share).
The company repurchased 2.5 million shares for approximately $24.8 million and increased its repurchase authorization to allow up to $300.0 million. For 2026, EverCommerce guided revenue of $612.0M–$632.0M and Adjusted EBITDA of $183.0M–$191.0M.
EverHealth (Nasdaq: EVCM) launched EverHealth Scribe, an AI-powered ambient documentation solution embedded in DrChrono to auto-generate structured visit notes from provider–patient conversations for provider review. According to CarePilot data, practices report saving an average of 8 minutes per visit and a 32% increase in same-day claim submissions.
The product is delivered via a strategic AI partnership with CarePilot and aims to reduce documentation burden, accelerate chart completion, and improve revenue cycle timing for independent practices.
EverCommerce (NASDAQ: EVCM) will report fourth quarter 2025 results after U.S. market close on Thursday, March 12, 2026.
Management will host a conference call the same day at 5:00 p.m. ET / 3:00 p.m. MT to discuss results and provide a business update; webcast and replay will be available on the company’s Investor Relations website.
EverCommerce (NASDAQ: EVCM) said CEO Eric Remer and SVP Finance & Head of Investor Relations Brad Korch will present and hold 1x1 meetings at the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference in New York on Tuesday, November 18, 2025.
The public presentation is scheduled for 3:20 p.m. EST. Live webcast links will be posted on the company’s Investor Relations site at https://investors.evercommerce.com.
EverCommerce (NASDAQ: EVCM) reported third quarter 2025 results for the period ended September 30, 2025. Revenue from continuing operations was $147.5M, up 5.3% year‑over‑year; Pro Forma Revenue was $148.3M (+5.3%). Adjusted EBITDA from continuing operations was $46.5M, versus $42.1M a year earlier. Net income from continuing operations was $5.8M ($0.03 per share) vs. a loss of $9.1M a year ago.
The company repurchased 2.6M shares for ~$29.1M and the Board approved a $50M increase in buyback authorization (total authorization up to $300M). Q4 2025 revenue guidance: $148M–$152M; FY2025 revenue guidance: $584M–$592M. Management noted the acquisition of ZyraTalk and cited isolated macro impacts in non‑SaaS revenue streams.
Ignite Visibility announced on October 31, 2025 the acquisition of EverConnect from EverCommerce (NASDAQ: EVCM), adding a marketing services platform focused on SEO, website development, lead generation, directory listings, and agency solutions for home services and healthcare businesses.
The deal expands Ignite’s product and service portfolio, follows Ignite’s fourth acquisition since partnering with Mountaingate Capital in February 2023, and was financed by Capital Southwest Corporation and Main Street Capital with advisers and counsel named for both parties.
EverCommerce (NASDAQ: EVCM) announced on October 31, 2025 that it sold its Marketing Technology solutions, collectively called EverConnect, to Ignite Visibility. EverConnect will operate as an integrated business within Ignite Visibility and continue to service existing customers. The sale concludes a strategic review that began in March.
EverCommerce said the divestiture lets it narrow focus on AI-powered vertical software to pursue long-term growth, margin accretion, and shareholder value. Canaccord Genuity advised EverCommerce; Greenberg Traurig and Morrison Foerster served as legal advisors. Terms of the sale were not disclosed.
EverCommerce (NASDAQ: EVCM) will report third quarter 2025 financial results after U.S. markets close on Thursday, November 6, 2025. Management will host a conference call the same day at 5:00 p.m. ET / 3:00 p.m. MT to discuss results and provide a business update. Investors can access the telephonic webcast and replay via the company Investor Relations page at https://investors.evercommerce.com/.